[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan – Following the 72nd Session of the World Health Organization Regional Committee for the Western Pacific, held in Himeji City, the City Government announced its participation in AMR Alliance Japan (November 17, 2021)
date : 11/17/2021
Tags: AMR
Himeji City announced its intention to join AMR Alliance Japan during a press conference held after the 72nd session of the World Health Organization Regional Committee for the Western Pacific (held in Himeji City from November 25 to November 29, 2021). The announcement makes Himeji City the first Government body to join the Alliance. Hideyasu Kiyomoto, the Mayor of Himeji City commented that Himeji City was going to consider serious steps to tackle the problem of AMR.
On September 25, 2021, prior to the World Health Organization Regional Committee for the Western Pacific, AMR Alliance Japan, Himeji City, Himeji Medical Association, and Himeji Dental Association hosted an official related event, “AMR: A Global Health Crisis -What We Can Do for the Fight Against the Silent Pandemic of AMR: Learning from COVID-19.” This event was supported by Ministry of Health, Labour and Welfare, Himeji Pharmacist Association and Hyogo Nursing Association Seiban Branch, and sponsored by Japan Pharmaceutical Manufacturers Association. The event stressed the urgency of AMR as a worldwide health crisis, and called for policy action at the global and local level.
Together with Himeji City and all of its members, AMR Alliance Japan will continue to promote the creation of stronger countermeasures against AMR through broad-based multisector collaboration.
■About AMR Alliance Japan AMR
AMR Alliance Japan was established in November 2018 as multi-stakeholder, collaborative organization dedicated to the improvement of public health through the promotion of AMR countermeasures. As of November 2021, its members include, in alphabetical order: Himeji City; The Japanese Association for Infectious Diseases; The Japanese Society for Chemotherapy; The Japanese Society for Clinical Microbiology; The Japanese Society for Medical Mycology; The Japanese Society for Pediatric Infectious Diseases; The Japanese Society of Infection Prevention and Control; The Japanese Society of Pharmaceutical Health Care and Sciences; The Japanese Society of Therapeutic Drug Monitoring; The Japan Medical Association; The Japan Pharmaceutical Association; The Japan Pharmaceutical Manufacturers Association; The Japan Society of Hospital Pharmacists; “Kodomo to Iryo” Project; MSD K.K.; Nippon Becton Dickinson Co., Ltd.; Pfizer Inc.; The Pharmaceutical Society of Japan; Shionogi & Co., Ltd. The Health and Global Policy Institute serves as the Secretariat of AMR Alliance Japan. Please scan the QR code at right to see our AMR Alliance Japan Website.
■Spreading Awareness about AMR in the Month of November
In Japan, the Cabinet Secretariat has designated November as “Antimicrobial Resistance (AMR) Awareness Month.” This aligns with “World Antimicrobial Awareness Week(WAAW),” which has been set for November 18 to November 24 this year by the WHO. This year’s theme is “Spread Awareness, Stop Resistance.”
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
Featured Posts
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
-
2024-11-01
[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)
-
2024-11-11
[Discussion Points] Women’s Health Project Expert Meeting “The Ideal System for Perinatal Medical Care in Japan in the Era of Declining Birth Rates” (November 11, 2024)
-
2024-11-11
[Registration Open] (Hybrid Format) Obesity Control Promotion Project Public Symposium “Obesity Control as a Social Issue; Toward the Realization of Citizen-Centered Policies” (December 4, 2024)
-
2024-11-14
[Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)